We have been focused on AI-driven biotech investments, and with our portfolio's growth and contributions to the life science industry, we are now building this fund to specifically focus on computational approaches to biological drug discovery and therapeutic delivery.
We are a team of leading research scientists and top-tier industry experts. We identify the most promising computational biotechnology innovations emerging from university research labs. We partner with professors, strategic investors, and companies to accelerate the development of novel therapeutic products.
All of our venture partners are deeply engaged in the portfolio companies, contributing to R&D development, management, fundraising support, and recruiting experienced industry experts to join the early founding teams.
People
- Georgia Lu, Founding Partner
You last contacted this investor on .